APO Research
Talk to an analyst

APO RESEARCH · REPORT

Preventable Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Preventable Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025197 pages

Choose your research edition.

Industry ResearchPreventable Vaccines Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Preventable Vaccines Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Preventable Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Preventable Vaccines Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Preventable Vaccines Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Preventable Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Preventable Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Preventable Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Preventable Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Preventable Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Preventable Vaccines include Bausch Health, Bavarian Nordic, Bharat Biotech, Crucell, Dynavax, Janssen Pharmaceuticals, LG Life Sciences, Lupin and Mitsubishi Tanabe Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Preventable Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Preventable Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Preventable Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Preventable Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Preventable Vaccines Segment by Company

Bausch Health

Bavarian Nordic

Bharat Biotech

Crucell

Dynavax

Janssen Pharmaceuticals

LG Life Sciences

Lupin

Mitsubishi Tanabe Pharma

Panacea Biotec

Protein Sciences

S K Chemicals

Serum Institute of India

Sinovac Biotech

Takeda Pharmaceutical

AstraZeneca

Baxter

GlaxoSmithKline

Pfizer

Roche

Merck

Novartis

Sanofi

Shenzhen Kangtai Biological Products

Abbott

Preventable Vaccines Segment by Type

Adult Preventable Vaccines

Pediatric Preventable Vaccines

Preventable Vaccines Segment by Application

Bacterial Diseases

Virus Diseases

Preventable Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preventable Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Preventable Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preventable Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Preventable Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Preventable Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Preventable Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Preventable Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Preventable Vaccines Industry Trends Table 2. Preventable Vaccines Industry Drivers Table 3. Preventable Vaccines Industry Opportunities and Challenges Table 4. Preventable Vaccines Industry Restraints Table 5. Global Preventable Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Preventable Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Preventable Vaccines Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Preventable Vaccines Sales Market Share by Manufacturers Table 9. Global Preventable Vaccines Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Preventable Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Preventable Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Preventable Vaccines Manufacturers, Product Type & Application Table 13. Global Preventable Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Preventable Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Adult Preventable Vaccines Table 17. Major Manufacturers of Pediatric Preventable Vaccines Table 18. Global Preventable Vaccines Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 19. Global Preventable Vaccines Sales by Type (2021-2026) & (W Units) Table 20. Global Preventable Vaccines Sales by Type (2027-2032) & (W Units) Table 21. Global Preventable Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Preventable Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Preventable Vaccines Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Preventable Vaccines Revenue by Type (2021-2026) & (W Units) Table 25. Global Preventable Vaccines Revenue by Type (2027-2032) & (W Units) Table 26. Global Preventable Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Preventable Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Bacterial Diseases Table 29. Major Manufacturers of Virus Diseases Table 30. Global Preventable Vaccines Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 31. Global Preventable Vaccines Sales by Application (2021-2026) & (W Units) Table 32. Global Preventable Vaccines Sales by Application (2027-2032) & (W Units) Table 33. Global Preventable Vaccines Sales Market Share by Application (2021-2026) Table 34. Global Preventable Vaccines Sales Market Share by Application (2027-2032) Table 35. Global Preventable Vaccines Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 36. Global Preventable Vaccines Revenue by Application (2021-2026) & (W Units) Table 37. Global Preventable Vaccines Revenue by Application (2027-2032) & (W Units) Table 38. Global Preventable Vaccines Revenue Market Share by Application (2021-2026) Table 39. Global Preventable Vaccines Revenue Market Share by Application (2027-2032) Table 40. Global Preventable Vaccines Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 41. Global Preventable Vaccines Sales by Region (2021-2026) & (W Units) Table 42. Global Preventable Vaccines Sales Market Share by Region (2021-2026) Table 43. Global Preventable Vaccines Sales Forecasted by Region (2027-2032) & (W Units) Table 44. Global Preventable Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Preventable Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 46. North America Preventable Vaccines Sales by Country (2021-2026) & (W Units) Table 47. North America Preventable Vaccines Sales by Country (2027-2032) & (W Units) Table 48. Europe Preventable Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 49. Europe Preventable Vaccines Sales by Country (2021-2026) & (W Units) Table 50. Europe Preventable Vaccines Sales by Country (2027-2032) & (W Units) Table 51. Asia Pacific Preventable Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. Asia Pacific Preventable Vaccines Sales by Country (2021-2026) & (W Units) Table 53. Asia Pacific Preventable Vaccines Sales by Country (2027-2032) & (W Units) Table 54. South America, Middle East and Africa Preventable Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. South America, Middle East and Africa Preventable Vaccines Sales by Country (2021-2026) & (W Units) Table 56. South America, Middle East and Africa Preventable Vaccines Sales by Country (2027-2032) & (W Units) Table 57. Global Preventable Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Preventable Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Preventable Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Preventable Vaccines Revenue Market Share by Region (2021-2026) Table 61. Global Preventable Vaccines Revenue Market Share by Region (2027-2032) Table 62. Bausch Health Company Information Table 63. Bausch Health Business Overview Table 64. Bausch Health Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Bausch Health Preventable Vaccines Product Portfolio Table 66. Bausch Health Recent Development Table 67. Bavarian Nordic Company Information Table 68. Bavarian Nordic Business Overview Table 69. Bavarian Nordic Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Bavarian Nordic Preventable Vaccines Product Portfolio Table 71. Bavarian Nordic Recent Development Table 72. Bharat Biotech Company Information Table 73. Bharat Biotech Business Overview Table 74. Bharat Biotech Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Bharat Biotech Preventable Vaccines Product Portfolio Table 76. Bharat Biotech Recent Development Table 77. Crucell Company Information Table 78. Crucell Business Overview Table 79. Crucell Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Crucell Preventable Vaccines Product Portfolio Table 81. Crucell Recent Development Table 82. Dynavax Company Information Table 83. Dynavax Business Overview Table 84. Dynavax Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Dynavax Preventable Vaccines Product Portfolio Table 86. Dynavax Recent Development Table 87. Janssen Pharmaceuticals Company Information Table 88. Janssen Pharmaceuticals Business Overview Table 89. Janssen Pharmaceuticals Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Janssen Pharmaceuticals Preventable Vaccines Product Portfolio Table 91. Janssen Pharmaceuticals Recent Development Table 92. LG Life Sciences Company Information Table 93. LG Life Sciences Business Overview Table 94. LG Life Sciences Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. LG Life Sciences Preventable Vaccines Product Portfolio Table 96. LG Life Sciences Recent Development Table 97. Lupin Company Information Table 98. Lupin Business Overview Table 99. Lupin Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Lupin Preventable Vaccines Product Portfolio Table 101. Lupin Recent Development Table 102. Mitsubishi Tanabe Pharma Company Information Table 103. Mitsubishi Tanabe Pharma Business Overview Table 104. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Mitsubishi Tanabe Pharma Preventable Vaccines Product Portfolio Table 106. Mitsubishi Tanabe Pharma Recent Development Table 107. Panacea Biotec Company Information Table 108. Panacea Biotec Business Overview Table 109. Panacea Biotec Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Panacea Biotec Preventable Vaccines Product Portfolio Table 111. Panacea Biotec Recent Development Table 112. Protein Sciences Company Information Table 113. Protein Sciences Business Overview Table 114. Protein Sciences Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Protein Sciences Preventable Vaccines Product Portfolio Table 116. Protein Sciences Recent Development Table 117. S K Chemicals Company Information Table 118. S K Chemicals Business Overview Table 119. S K Chemicals Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. S K Chemicals Preventable Vaccines Product Portfolio Table 121. S K Chemicals Recent Development Table 122. Serum Institute of India Company Information Table 123. Serum Institute of India Business Overview Table 124. Serum Institute of India Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Serum Institute of India Preventable Vaccines Product Portfolio Table 126. Serum Institute of India Recent Development Table 127. Sinovac Biotech Company Information Table 128. Sinovac Biotech Business Overview Table 129. Sinovac Biotech Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Sinovac Biotech Preventable Vaccines Product Portfolio Table 131. Sinovac Biotech Recent Development Table 132. Takeda Pharmaceutical Company Information Table 133. Takeda Pharmaceutical Business Overview Table 134. Takeda Pharmaceutical Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Takeda Pharmaceutical Preventable Vaccines Product Portfolio Table 136. Takeda Pharmaceutical Recent Development Table 137. AstraZeneca Company Information Table 138. AstraZeneca Business Overview Table 139. AstraZeneca Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. AstraZeneca Preventable Vaccines Product Portfolio Table 141. AstraZeneca Recent Development Table 142. Baxter Company Information Table 143. Baxter Business Overview Table 144. Baxter Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Baxter Preventable Vaccines Product Portfolio Table 146. Baxter Recent Development Table 147. GlaxoSmithKline Company Information Table 148. GlaxoSmithKline Business Overview Table 149. GlaxoSmithKline Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. GlaxoSmithKline Preventable Vaccines Product Portfolio Table 151. GlaxoSmithKline Recent Development Table 152. Pfizer Company Information Table 153. Pfizer Business Overview Table 154. Pfizer Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Pfizer Preventable Vaccines Product Portfolio Table 156. Pfizer Recent Development Table 157. Roche Company Information Table 158. Roche Business Overview Table 159. Roche Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 160. Roche Preventable Vaccines Product Portfolio Table 161. Roche Recent Development Table 162. Merck Company Information Table 163. Merck Business Overview Table 164. Merck Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 165. Merck Preventable Vaccines Product Portfolio Table 166. Merck Recent Development Table 167. Novartis Company Information Table 168. Novartis Business Overview Table 169. Novartis Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 170. Novartis Preventable Vaccines Product Portfolio Table 171. Novartis Recent Development Table 172. Sanofi Company Information Table 173. Sanofi Business Overview Table 174. Sanofi Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 175. Sanofi Preventable Vaccines Product Portfolio Table 176. Sanofi Recent Development Table 177. Shenzhen Kangtai Biological Products Company Information Table 178. Shenzhen Kangtai Biological Products Business Overview Table 179. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 180. Shenzhen Kangtai Biological Products Preventable Vaccines Product Portfolio Table 181. Shenzhen Kangtai Biological Products Recent Development Table 182. Abbott Company Information Table 183. Abbott Business Overview Table 184. Abbott Preventable Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 185. Abbott Preventable Vaccines Product Portfolio Table 186. Abbott Recent Development Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Preventable Vaccines Distributors List Table 190. Preventable Vaccines Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Preventable Vaccines Product Image Figure 2. Global Preventable Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Preventable Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Preventable Vaccines Sales (2021-2032) & (W Units) Figure 5. Global Preventable Vaccines Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Preventable Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Adult Preventable Vaccines Image Figure 9. Pediatric Preventable Vaccines Image Figure 10. Global Preventable Vaccines Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 11. Global Preventable Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Preventable Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Preventable Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Preventable Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Preventable Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Bacterial Diseases Image Figure 17. Virus Diseases Image Figure 18. Global Preventable Vaccines Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 19. Global Preventable Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Preventable Vaccines Sales Market Share by Application (2021-2032) Figure 21. Global Preventable Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Preventable Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Preventable Vaccines Revenue Market Share by Application (2021-2032) Figure 24. North America Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 25. North America Preventable Vaccines Sales Market Share by Country (2021-2032) Figure 26. U.S. Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 27. Canada Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 28. Mexico Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Europe Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Europe Preventable Vaccines Sales Market Share by Country (2021-2032) Figure 31. Germany Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 32. France Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 33. U.K. Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Italy Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Netherlands Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Asia Pacific Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Asia Pacific Preventable Vaccines Sales Market Share by Country (2021-2032) Figure 38. China Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Japan Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 40. South Korea Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Southeast Asia Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 42. India Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Australia Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 44. South America, Middle East and Africa Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 45. South America, Middle East and Africa Preventable Vaccines Sales Market Share by Country (2021-2032) Figure 46. Brazil Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South Africa Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 48. Saudi Arabia Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Turkey Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Argentina Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 51. UAE Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Egypt Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Chile Preventable Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Global Preventable Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Preventable Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Preventable Vaccines Revenue (2021-2032) & (US$ Million) Figure 57. North America Preventable Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Preventable Vaccines Revenue (2021-2032) & (US$ Million) Figure 59. Europe Preventable Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Preventable Vaccines Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Preventable Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Preventable Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Preventable Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Preventable Vaccines Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Preventable Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Adult Preventable Vaccines
  • Pediatric Preventable Vaccines
Applications
  • Bacterial Diseases
  • Virus Diseases
Companies covered
  • Bausch Health
  • Bavarian Nordic
  • Bharat Biotech
  • Crucell
  • Dynavax
  • Janssen Pharmaceuticals
  • LG Life Sciences
  • Lupin
  • Mitsubishi Tanabe Pharma
  • Panacea Biotec
  • Protein Sciences
  • S K Chemicals
  • Serum Institute of India
  • Sinovac Biotech
  • Takeda Pharmaceutical
  • AstraZeneca
  • Baxter
  • GlaxoSmithKline
  • Pfizer
  • Roche
  • Merck
  • Novartis
  • Sanofi
  • Shenzhen Kangtai Biological Products
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Preventable Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Preventable Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Preventable Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Preventable Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Preventable Vaccines Market Dynamics
  1. 2.1 Preventable Vaccines Industry Trends
  2. 2.2 Preventable Vaccines Industry Drivers
  3. 2.3 Preventable Vaccines Industry Opportunities and Challenges
  4. 2.4 Preventable Vaccines Industry Restraints
3 Preventable Vaccines Market by Manufacturers
  1. 3.1 Global Preventable Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Preventable Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Preventable Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Preventable Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Preventable Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Preventable Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Preventable Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Preventable Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Preventable Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Preventable Vaccines Tier 1, Tier 2, and Tier 3
4 Preventable Vaccines Market by Type
  1. 4.1 Preventable Vaccines Type Introduction
  2. 4.1.1 Adult Preventable Vaccines
  3. 4.1.2 Pediatric Preventable Vaccines
  4. 4.2 Global Preventable Vaccines Sales by Type
  5. 4.2.1 Global Preventable Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Preventable Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Preventable Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Preventable Vaccines Revenue by Type
  9. 4.3.1 Global Preventable Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Preventable Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Preventable Vaccines Revenue Market Share by Type (2021-2032)
5 Preventable Vaccines Market by Application
  1. 5.1 Preventable Vaccines Application Introduction
  2. 5.1.1 Bacterial Diseases
  3. 5.1.2 Virus Diseases
  4. 5.2 Global Preventable Vaccines Sales by Application
  5. 5.2.1 Global Preventable Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Preventable Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global Preventable Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global Preventable Vaccines Revenue by Application
  9. 5.3.1 Global Preventable Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Preventable Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global Preventable Vaccines Revenue Market Share by Application (2021-2032)
6 Global Preventable Vaccines Sales by Region
  1. 6.1 Global Preventable Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Preventable Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Preventable Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Preventable Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Preventable Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Preventable Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Preventable Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Preventable Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Preventable Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Preventable Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Preventable Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Preventable Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Preventable Vaccines Revenue by Region
  1. 7.1 Global Preventable Vaccines Revenue by Region
  2. 7.1.1 Global Preventable Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Preventable Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Preventable Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Preventable Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Preventable Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Preventable Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Preventable Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Preventable Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Preventable Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Preventable Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Preventable Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Preventable Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bausch Health
  2. 8.1.1 Bausch Health Company Information
  3. 8.1.2 Bausch Health Business Overview
  4. 8.1.3 Bausch Health Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bausch Health Preventable Vaccines Product Portfolio
  6. 8.1.5 Bausch Health Recent Developments
  7. 8.2 Bavarian Nordic
  8. 8.2.1 Bavarian Nordic Company Information
  9. 8.2.2 Bavarian Nordic Business Overview
  10. 8.2.3 Bavarian Nordic Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bavarian Nordic Preventable Vaccines Product Portfolio
  12. 8.2.5 Bavarian Nordic Recent Developments
  13. 8.3 Bharat Biotech
  14. 8.3.1 Bharat Biotech Company Information
  15. 8.3.2 Bharat Biotech Business Overview
  16. 8.3.3 Bharat Biotech Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bharat Biotech Preventable Vaccines Product Portfolio
  18. 8.3.5 Bharat Biotech Recent Developments
  19. 8.4 Crucell
  20. 8.4.1 Crucell Company Information
  21. 8.4.2 Crucell Business Overview
  22. 8.4.3 Crucell Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Crucell Preventable Vaccines Product Portfolio
  24. 8.4.5 Crucell Recent Developments
  25. 8.5 Dynavax
  26. 8.5.1 Dynavax Company Information
  27. 8.5.2 Dynavax Business Overview
  28. 8.5.3 Dynavax Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Dynavax Preventable Vaccines Product Portfolio
  30. 8.5.5 Dynavax Recent Developments
  31. 8.6 Janssen Pharmaceuticals
  32. 8.6.1 Janssen Pharmaceuticals Company Information
  33. 8.6.2 Janssen Pharmaceuticals Business Overview
  34. 8.6.3 Janssen Pharmaceuticals Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Janssen Pharmaceuticals Preventable Vaccines Product Portfolio
  36. 8.6.5 Janssen Pharmaceuticals Recent Developments
  37. 8.7 LG Life Sciences
  38. 8.7.1 LG Life Sciences Company Information
  39. 8.7.2 LG Life Sciences Business Overview
  40. 8.7.3 LG Life Sciences Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LG Life Sciences Preventable Vaccines Product Portfolio
  42. 8.7.5 LG Life Sciences Recent Developments
  43. 8.8 Lupin
  44. 8.8.1 Lupin Company Information
  45. 8.8.2 Lupin Business Overview
  46. 8.8.3 Lupin Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lupin Preventable Vaccines Product Portfolio
  48. 8.8.5 Lupin Recent Developments
  49. 8.9 Mitsubishi Tanabe Pharma
  50. 8.9.1 Mitsubishi Tanabe Pharma Company Information
  51. 8.9.2 Mitsubishi Tanabe Pharma Business Overview
  52. 8.9.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mitsubishi Tanabe Pharma Preventable Vaccines Product Portfolio
  54. 8.9.5 Mitsubishi Tanabe Pharma Recent Developments
  55. 8.10 Panacea Biotec
  56. 8.10.1 Panacea Biotec Company Information
  57. 8.10.2 Panacea Biotec Business Overview
  58. 8.10.3 Panacea Biotec Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Panacea Biotec Preventable Vaccines Product Portfolio
  60. 8.10.5 Panacea Biotec Recent Developments
  61. 8.11 Protein Sciences
  62. 8.11.1 Protein Sciences Company Information
  63. 8.11.2 Protein Sciences Business Overview
  64. 8.11.3 Protein Sciences Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Protein Sciences Preventable Vaccines Product Portfolio
  66. 8.11.5 Protein Sciences Recent Developments
  67. 8.12 S K Chemicals
  68. 8.12.1 S K Chemicals Company Information
  69. 8.12.2 S K Chemicals Business Overview
  70. 8.12.3 S K Chemicals Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 S K Chemicals Preventable Vaccines Product Portfolio
  72. 8.12.5 S K Chemicals Recent Developments
  73. 8.13 Serum Institute of India
  74. 8.13.1 Serum Institute of India Company Information
  75. 8.13.2 Serum Institute of India Business Overview
  76. 8.13.3 Serum Institute of India Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Serum Institute of India Preventable Vaccines Product Portfolio
  78. 8.13.5 Serum Institute of India Recent Developments
  79. 8.14 Sinovac Biotech
  80. 8.14.1 Sinovac Biotech Company Information
  81. 8.14.2 Sinovac Biotech Business Overview
  82. 8.14.3 Sinovac Biotech Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sinovac Biotech Preventable Vaccines Product Portfolio
  84. 8.14.5 Sinovac Biotech Recent Developments
  85. 8.15 Takeda Pharmaceutical
  86. 8.15.1 Takeda Pharmaceutical Company Information
  87. 8.15.2 Takeda Pharmaceutical Business Overview
  88. 8.15.3 Takeda Pharmaceutical Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Takeda Pharmaceutical Preventable Vaccines Product Portfolio
  90. 8.15.5 Takeda Pharmaceutical Recent Developments
  91. 8.16 AstraZeneca
  92. 8.16.1 AstraZeneca Company Information
  93. 8.16.2 AstraZeneca Business Overview
  94. 8.16.3 AstraZeneca Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 AstraZeneca Preventable Vaccines Product Portfolio
  96. 8.16.5 AstraZeneca Recent Developments
  97. 8.17 Baxter
  98. 8.17.1 Baxter Company Information
  99. 8.17.2 Baxter Business Overview
  100. 8.17.3 Baxter Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Baxter Preventable Vaccines Product Portfolio
  102. 8.17.5 Baxter Recent Developments
  103. 8.18 GlaxoSmithKline
  104. 8.18.1 GlaxoSmithKline Company Information
  105. 8.18.2 GlaxoSmithKline Business Overview
  106. 8.18.3 GlaxoSmithKline Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 GlaxoSmithKline Preventable Vaccines Product Portfolio
  108. 8.18.5 GlaxoSmithKline Recent Developments
  109. 8.19 Pfizer
  110. 8.19.1 Pfizer Company Information
  111. 8.19.2 Pfizer Business Overview
  112. 8.19.3 Pfizer Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Pfizer Preventable Vaccines Product Portfolio
  114. 8.19.5 Pfizer Recent Developments
  115. 8.20 Roche
  116. 8.20.1 Roche Company Information
  117. 8.20.2 Roche Business Overview
  118. 8.20.3 Roche Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Roche Preventable Vaccines Product Portfolio
  120. 8.20.5 Roche Recent Developments
  121. 8.21 Merck
  122. 8.21.1 Merck Company Information
  123. 8.21.2 Merck Business Overview
  124. 8.21.3 Merck Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Merck Preventable Vaccines Product Portfolio
  126. 8.21.5 Merck Recent Developments
  127. 8.22 Novartis
  128. 8.22.1 Novartis Company Information
  129. 8.22.2 Novartis Business Overview
  130. 8.22.3 Novartis Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Novartis Preventable Vaccines Product Portfolio
  132. 8.22.5 Novartis Recent Developments
  133. 8.23 Sanofi
  134. 8.23.1 Sanofi Company Information
  135. 8.23.2 Sanofi Business Overview
  136. 8.23.3 Sanofi Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Sanofi Preventable Vaccines Product Portfolio
  138. 8.23.5 Sanofi Recent Developments
  139. 8.24 Shenzhen Kangtai Biological Products
  140. 8.24.1 Shenzhen Kangtai Biological Products Company Information
  141. 8.24.2 Shenzhen Kangtai Biological Products Business Overview
  142. 8.24.3 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Shenzhen Kangtai Biological Products Preventable Vaccines Product Portfolio
  144. 8.24.5 Shenzhen Kangtai Biological Products Recent Developments
  145. 8.25 Abbott
  146. 8.25.1 Abbott Company Information
  147. 8.25.2 Abbott Business Overview
  148. 8.25.3 Abbott Preventable Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Abbott Preventable Vaccines Product Portfolio
  150. 8.25.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Preventable Vaccines Value Chain Analysis
  2. 9.1.1 Preventable Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Preventable Vaccines Production Mode & Process
  6. 9.2 Preventable Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Preventable Vaccines Distributors
  9. 9.2.3 Preventable Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst